Public interest in psychedelics and adult use has grown alongside research into their clinical potential. A landscape analysis of online, publicly available information identified 298 organizations offering psychedelic retreats to English-speaking consumers between July and December 2023. Most organizations focused on general wellness rather than religious identity. Ayahuasca was the most commonly offered substance, followed by psilocybin and San Pedro. Retreats were held at 440 distinct physical locations worldwide, with 130 inside the United States and 310 outside. Prices varied widely. Further research into retreat practices is recommended to reduce harm and support consumer education.
People use psilocybin for different reasons depending on whether they take a microdose (0.1–0.4 g) or a macrodose (1 g+), each producing distinct perceptual and mood effects. An online survey measured motives with an adapted Marijuana Motives Measure and found statistically significant differences in motives between the two doses. A thematic analysis further revealed that motives also differ for initiating versus continuing use. These results suggest that harm reduction and public policy should account for dosage-specific motivations.